These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 12527709)

  • 1. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
    Nascimento AF; Hirsch MS; Cviko A; Quade BJ; Nucci MR
    Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
    Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
    Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
    Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
    Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis.
    Srodon M; Klein WM; Kurman RJ
    Am J Surg Pathol; 2003 Jun; 27(6):786-9. PubMed ID: 12766582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
    Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
    Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis.
    Mittal KR; Barwick KW
    Gynecol Oncol; 1993 May; 49(2):197-201. PubMed ID: 8504988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFITM1 Is Superior to CD10 as a Marker of Endometrial Stroma in the Evaluation of Myometrial Invasion by Endometrioid Adenocarcinoma.
    Busca A; Djordjevic B; Giassi A; Parra-Herran C
    Am J Clin Pathol; 2016 Apr; 145(4):486-96. PubMed ID: 27124937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 expression in adenomyosis in endometrial carcinoma patients.
    Taskin M; Lallas TA; Shevchuk M; Barber HR
    Gynecol Oncol; 1996 Aug; 62(2):241-6. PubMed ID: 8751556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
    Chu PG; Arber DA; Weiss LM; Chang KL
    Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprofile of endocervical and endometrial stromal cells and its potential application in localization of tumor involvement.
    Barroeta JE; Pasha TL; Acs G; Zhang PJ
    Int J Gynecol Pathol; 2007 Jan; 26(1):76-82. PubMed ID: 17197901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusely infiltrating endometrial carcinomas with no stromal response: report of a series, including cases with cervical and ovarian involvement and emphasis on the potential for misdiagnosis.
    Kalyanasundaram K; Ganesan R; Perunovic B; McCluggage WG
    Int J Surg Pathol; 2010 Apr; 18(2):138-43. PubMed ID: 19117974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular retinol-binding protein-1 expression in endometrial stromal cells: physiopathological and diagnostic implications.
    Orlandi A; Ferlosio A; Ciucci A; Sesti F; Lifschitz-Mercer B; Gabbiani G; Spagnoli LG; Czernobilsky B
    Histopathology; 2004 Nov; 45(5):511-7. PubMed ID: 15500655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of tumor involved adenomyosis in otherwise low-stage endometrioid adenocarcinoma.
    Hanley KZ; Dustin SM; Stoler MH; Atkins KA
    Int J Gynecol Pathol; 2010 Sep; 29(5):445-51. PubMed ID: 20736770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases.
    Jacques SM; Lawrence WD
    Gynecol Oncol; 1990 Jun; 37(3):401-7. PubMed ID: 2351325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma.
    Chu P; Arber DA
    Am J Clin Pathol; 2000 Mar; 113(3):374-82. PubMed ID: 10705818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serous endometrial intraepithelial carcinoma arising in adenomyosis: a report of 5 cases.
    Abushahin N; Zhang T; Chiang S; Zhang X; Hatch K; Zheng W
    Int J Gynecol Pathol; 2011 May; 30(3):271-81. PubMed ID: 21464726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma.
    Götte M; Wolf M; Staebler A; Buchweitz O; Kelsch R; Schüring AN; Kiesel L
    J Pathol; 2008 Jul; 215(3):317-29. PubMed ID: 18473332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases.
    Lu B; Chen Q; Zhang X; Cheng L
    Diagn Pathol; 2016 Jun; 11(1):46. PubMed ID: 27260518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.